Consistently, the inhibition of the NLRP3 inflammasome, which activates caspase-1 to promote the maturation and release of IL-18, has also been shown to reduce inflammatory cytokines after traumatic brain injury [43]. The gene discussed is NLRP3; the disease is injury.